Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al
Case Number:
2:22-cv-00750
Court:
Nature of Suit:
Judge:
Firms
- Avantech Law
- Desmarais LLP
- Eckert Seamans
- Epstein Becker
- McCurdy Laud
- Morrison Foerster
- Perkins Coie
- Pietragallo Gordon
Companies
Sectors & Industries:
-
September 21, 2022
Viatris Suppliers Want Out Of J&J Unit's MS Drug IP Suit
Three drug manufacturers for Viatris have urged a Pennsylvania federal judge to cut them loose from a patent suit lodged by a Johnson & Johnson branch over a generic multiple sclerosis treatment, arguing that the court lacks jurisdiction and the overseas suppliers can't be held liable for the allegedly infringing products.
-
May 24, 2022
Mylan Hit With Infringement Suit Over MS Generic Drug
Mylan has been using Momenta's patented manufacturing methods to make a generic version of a multiple sclerosis treatment, the Johnson & Johnson unit alleged in a new infringement lawsuit in Pennsylvania federal court.